MITORett · Deciphering cerebellar mitochondrial alterations in Rett Syndrome
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2021-05-01 → 2023-11-18
- Финансиране от ЕС
- 172 932 €
- Участници
- 1
- Схема
- MSCA-IF
Линиите свързват координатора с партньорите.
Накратко на български
Промените в митохондриите на специфични неврони в малкия мозък се анализират при синдрома на Рет. Това помага за разбирането на механизмите, които водят до загуба на речта и двигателната координация при засегнатите хора.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Deciphering cerebellar mitochondrial alterations in Rett Syndrome
Rett syndrome is a progressive neurodegenerative disorder caused by mutations in the Mecp2 gene and affecting primarily women. Although individuals with Rett syndrome initially exhibit typical development during the initial years of life, they subsequently experience a rapid regression, losing language and motor coordination skills. This regression is accompanied by the development of cognitive deficits, stereotyped hand movements, ataxia, seizures, respiratory dysrhythmias, and alterations in social behavior. Despite available treatments to alleviate symptoms, there's still no cure for Rett syndrome disease. The MECP2 protein plays a pivotal role in regulating gene expression, and mutations in MECP2 directly impact its target genes. Animal models, particularly those focusing on specific brain cell types, have contributed valuable insights into the underlying mechanisms of the syndrome. In a study involving a mouse model of Rett Syndrome where Mecp2 was suppressed in a particular sub-type of inhibitory neurons known as Parvalbumin-neurons, motor impairments, spasticity, social and memory deficits, and premature lethality were observed in Rett Syndrome mice. Parvalbumin-neurons, characterized by substantial energy requirements, are distributed across various brain regions, including the cerebellum, a region with significant energy demands and a substantial population of Parvalbumin-neurons. Mitochondria, essential cellular organelles, play a pivotal role in energy production. Previous studies have reported mitochondrial alterations in individuals with Rett Syndrome, despite that the specific regional and cellular identity of these alterations remain unexplored. This project hypothesizes that cerebellar Parvalbumin-positive neurons, with their pronounced energy requirements, may be particularly vulnerable to mitochondrial alterations in Rett Syndrome. To address this hypothesis, the research proposal suggests analyzing whether the expression of mitochondrial proteins in cerebellar Parvalbumin-neurons is affected by the Mecp2 mutation. Additionally, an examination of potential modifications in mitochondrial functionality in Rett Syndrome mice is proposed. To accomplish this, histological and transcriptomic experiments have been conducted in a mouse model with Mecp2 suppression in Parvalbumin-neurons. Ongoing proteomic and functional experiments that are under compilation will complement this work.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Mutations in the X-linked gene encoding methyl-CpG binding protein 2 (Mecp2) can lead to the progressive neurodevelopmental disorder known as Rett syndrome (RTT), characterized by regression in motor, social and cognitive skills, respiratory dysrhythmias and premature lethality. Although few symptomatic treatments exist, nowadays there is still no cure for this disease. Mecp2 acts as transcriptional regulator and its mutations directly affect the expression of targeted transcripts, including mitochondrial (MT) genes. Cerebellum is one of brain regions with larger energy requirements. 43% of its ATP consumption occurs in the molecular layer, where the high-energy demanding parvalbumin (PV)-neurons are positioned. Compelling evidence indicates aberrant MT morphology and functionality in cerebellar biopsies of RTT patients. However, the cellular substrate of these modifications remains largely unknown. In adult cerebellum Mecp2 is preferentially expressed in PV-positive cells. Hence, we hypothesize that RTT in PV-positive neurons might present a particular vulnerability to MT alterations. Thus, in this proposal I will implement a multidisciplinary approach to find candidate MT proteins differentially regulated in cerebellar PV-positive neurons associated with the MT impairments observed in RTT. To tackle this aim, I will perform proteomic, functional and metabolomic studies in MT immunoprecipitates from cerebellar PV-positive neurons of RTT mice. This project will thus give raise to: i) the first exhaustive list of MT proteins dysregulated in these cells in RTT ii) identification of functional and metabolomic impairments affecting MT functionality in PV-positive cells of RTT mice.MITORett project will be a breakthrough in our understanding of RTT and it will provide novel insights into the pathophysiology of this disease by unveiling potential therapeutical targets to focus the forthcoming experiments dedicated on the design of more selective drugs/treatments.
Оригинален текст от CORDIS (на английски).
Участници
- UNIVERSITAT AUTONOMA DE BARCELONA · Cerdanyola Del VallesКоординаторИспания
Връзки
- Виж в CORDIS
- DOI: 10.3030/101028078
- https://portalrecerca.uab.cat/en/projects/deciphering-cerebellar-mitochondrial-alterations-in-rett-syndrome-2
Данни: CORDIS, © Европейски съюз
